LS Investment Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,971
Closed -$205K 422
2021
Q1
$205K Sell
2,971
-1,024
-26% -$69.4K 0.01% 763
2020
Q4
$259K Buy
+3,995
New +$215K 0.01% 692
2020
Q3
Sell
-3,995
Closed -$188K 1092
2020
Q2
$188K Buy
3,995
+166
+4% +$8.16K 0.01% 758
2020
Q1
$171K Hold
3,829
0.01% 689
2019
Q4
$223K Sell
3,829
-1,331
-26% -$79.2K 0.01% 755
2019
Q3
$310K Buy
5,160
+119
+2% +$7.09K 0.02% 609
2019
Q2
$282K Sell
5,041
-322
-6% -$16.6K 0.02% 644
2019
Q1
$299K Buy
5,363
+38
+0.7% +$1.94K 0.02% 636
2018
Q4
$240K Buy
5,325
+1,185
+29% +$65K 0.02% 674
2018
Q3
$273K Sell
4,140
-136
-3% -$8.45K 0.02% 725
2018
Q2
$275K Buy
4,276
+2,130
+99% +$132K 0.02% 738
2018
Q1
$119K Buy
2,146
+118
+6% +$6.18K 0.01% 1062
2017
Q4
$97K Sell
2,028
-358
-15% -$17.5K 0.01% 1139
2017
Q3
$120K Sell
2,386
-137
-5% -$7.04K 0.01% 1102
2017
Q2
$138K Buy
2,523
+111
+5% +$5.3K 0.01% 1026
2017
Q1
$102K Sell
2,412
-118
-5% -$5.04K 0.01% 1114
2016
Q4
$109K Buy
2,530
+16
+0.6% +$650 0.01% 1015
2016
Q3
$104K Buy
2,514
+72
+3% +$3.02K 0.01% 996
2016
Q2
$97K Buy
2,442
+186
+8% +$6.69K 0.01% 1005
2016
Q1
$76K Buy
2,256
+110
+5% +$3.43K 0.01% 983
2015
Q4
$73K Buy
2,146
+100
+5% +$3.13K 0.01% 990
2015
Q3
$61K Sell
2,046
-310
-13% -$9.69K ﹤0.01% 1053
2015
Q2
$65K Buy
+2,356
New +$62.8K ﹤0.01% 1061

Other funds holding IART

LS Investment Advisors's IART Position: Q2 2021 in Review

LS Investment Advisors sold out of Integra LifeSciences (IART) in Q2 2021, closing a stake of 2,971 shares — an estimated $205K sold.

LS Investment Advisors first reported a position in IART in Q2 2015 and held it in 23 quarters. The position peaked at $310K in Q3 2019. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

  • LS Investment Advisors reported no remaining Integra LifeSciences position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 2,971 Integra LifeSciences shares in Q2 2021, an estimated $205K.
  • LS Investment Advisors first reported a position in Integra LifeSciences in Q2 2015 and held it in 23 quarters.
  • LS Investment Advisors's Integra LifeSciences position peaked at $310K in Q3 2019.
  • 264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.